Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS

450Citations
Citations of this article
219Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mitochondria manganese superoxide dismutase (SOD2) is an important antioxidant enzyme, deficiency of which is associated with various human diseases. The known primary regulation of SOD2 is through transcriptional activation. Here, we report that SOD2 is acetylated at Lys 68 and that this acetylation decreases SOD2 activity. Mitochondrial deacetylase SIRT3 binds to, deacetylates and activates SOD2. Increase of reactive oxygen species (ROS) levels stimulates SIRT3 transcription, leading to SOD2 deacetylation and activation. SOD2-mediated ROS reduction is synergistically increased by SIRT3 co-expression, but is cancelled by SIRT3 depletion. These results reveal a new post-translational regulation of SOD2 by means of acetylation and SIRT3-dependent deacetylation in response to oxidative stress. © 2011 European Molecular Biology Organization.

Author supplied keywords

Cite

CITATION STYLE

APA

Chen, Y., Zhang, J., Lin, Y., Lei, Q., Guan, K. L., Zhao, S., & Xiong, Y. (2011). Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Reports, 12(6), 534–541. https://doi.org/10.1038/embor.2011.65

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free